KRAS and familial pancreatic carcinoma: In most pancreatic cancer patients, proto-oncogenes such as KRAS (Kirsten rat sarcoma viral oncogene homolog) are constitutionally activated, leading to uncontrolled cell proliferation, apoptotic resistance, and other oncogenic cascades [11,12].